Former Partners’ Dispute over $130 Million Crypto Assets Heads to Trial

An ongoing legal battle that centers around the acrimonious disentanglement of former partners and their shared digital assets is set to be decided by a trial, according to a New York judge’s ruling. The crux of the dispute involves accusations that a nascent litigation boutique strategically ejected a founding partner to gain control over his portion of a cryptocurrency.

The litigation boutique firm, Freedman Normand Friedland, has been accused of using undue means to oust one of its founding partners, Jason Cryulnik. The firm has countered the allegations, claiming that Cryulnik brought about his own dismissal through abusive conduct. The firm’s contention is that Cryulnik’s firing was not only warranted but was conducted in strict accordance with an existing memorandum of understanding drafted at the inception of the firm.

Despite these assertions, Cryulnik continues to push back against his former partners, alleging that they conspired to forcibly remove him to pilfer his portion of a cryptocurrency the firm received in return for the legal services it provided to the blockchain startup Ava Labs. The cryptocurrency in question, the Ava Labs token (AVAX), substantially increased in value shortly before Cryulnik’s dismissal. The firm’s stake in the token is purportedly worth around $130 million.

The predicament lays bare the hazards associated with starting a boutique firm from the ground up and the unforeseen ramifications of receiving digital currencies as payment for services rendered.

The firm Freedman Normand Friedland and Cryulnik have declined to comment regarding the pending trial. The contentious affair underscores the deep-seated issues present within the relatively untrodden path of digital currency in legal services. It also highlights the inherent challenges faced in forming a boutique firm, particularly issues around significant changes in the value of non-standard forms of remuneration such as cryptocurrency.

Details of the upcoming trial can be found in the case Roche Freedman LLP v. Cyrulnik.

Further reading on this topic can be found here.